Skip to main content

Table 4 Significant variants in COL6A3 associated with lung susceptibility after stratified by age of 61 years

From: COL6A3 polymorphisms were associated with lung cancer risk in a Chinese population

Gene

SNP

Model

Genotype

Control

Case

Age>61 years

Age ≤ 61 years

OR (95%CI)

p-value

OR (95%CI)

p-value

COL6A3

rs115510139

Codominant

A/A

131 (26.7%)

108 (21.2%)

1.00

 

1.00

 

A/T

232 (47.3%)

235 (46.1%)

0.77 (0.51–1.16)

0.212

1.40 (0.89–2.21)

0.143

T/T

127 (26.0%)

167 (32.7%)

0.71 (0.43–1.16)

0.167

1.84 (1.12–3.03)

0.016

Dominant

A/A

131 (26.7%)

108 (21.2%)

1.00

0.142

1.00

0.037

T/A-T/T

359 (73.3%)

402 (78.8%)

0.75 (0.51–1.10)

1.56 (1.03–2.38)

Recessive

A/A-A/T

363 (74.0%)

343 (67.3%)

1.00

0.393

1.00

0.055

T/T

127 (26.0%)

167 (32.7%)

0.83 (0.55–1.27)

1.48 (0.99–2.22)

Log-additive

0.84 (0.66–1.07)

0.154

1.36 (1.06–1.74)

0.016

  1. Bold type indicates statistical significance (p < 0.05)
  2. SNP Single nucleotide polymorphism, OR Odds ratio, 95%CI 95% confidence interval
  3. p: p-values were calculated by logistic regression analysis with adjustment for gender